Tanja Novakovic

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications

Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek et al. · PharmacoEconomics · 2017 · 121 citations · Full text

Public Affairs, Pharmaceutical Policy, Health Technology Assessment +8

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Generics and Biosimilars Initiative Journal · 2019 · 45 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17

Evaluating the Serbian version of the KIDSCREEN quality-of-life questionnaires: reliability, validity, and agreement between children’s and parents’ ratings

Dejan Stevanović, Ivana Tadić, Tanja Novakovic et al. · Quality of Life Research · 2012 · 33 citations

Social Sciences, Child Health, Psychology +14

The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan

Wija Oortwijn, Gavin Surgey, Tanja Novakovic et al. · International Journal of Environmental Research and Public Health · 2022 · 13 citations · Full text

Public Affairs, Health Policy, Health Sciences +17